A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1994
12/21/1994	EP0220273B1 Synthetic antigens for the detection of aids-related disease
12/21/1994	CN1096584A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of hla-c-clone 10/mage-1 derived peptides, and method for treating said.........
12/21/1994	CN1096516A Improved meningococoal polysaccharide conjugate vaccine
12/20/1994	US5374717 Sequences of the hemagglutinins of recent strains of influenza type B virus
12/20/1994	US5374655 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures
12/20/1994	US5374618 Calcitonin peptides, and gene related pharmaceutical compositions
12/20/1994	US5374550 Thyroid-derived chondrocyte-stimulating factor
12/20/1994	US5374549 Treating tumors; culturing with suppression of expansion of adherent lymphokine-activated killer(A-LAK) cells
12/20/1994	US5374529 Methods of and compositions for diagnosis, monitoring and treating the early stages of osteoarthritis
12/20/1994	US5374517 IM peptides
12/20/1994	US5374426 Rotavirus nucleocapsid protein VP6 in vaccine compositions
12/20/1994	US5374424 Multivalent felv-infected feline vaccine
12/20/1994	US5374423 Method of using cytokine receptors on microorganism
12/20/1994	CA1333563C Synthetic vaccine against foot and mouth disease and a process for the preparation thereof
12/20/1994	CA1333562C Preservation of viruses
12/17/1994	CA2125793A1 Organic compounds
12/14/1994	EP0628639A1 Reconstituted human antibody against human interleukin 6 receptor
12/14/1994	EP0628633A1 Recombinant herpes simplex gB-gD vaccine
12/14/1994	EP0628572A2 DNA originating in non-A non-B hepatitis virus gene and constituting polypeptide
12/14/1994	EP0628570A1 Method for the use and synthesis of peptides
12/14/1994	EP0628315A1 Lectin complex and probe and method for making same
12/14/1994	EP0628084A1 Monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus
12/14/1994	EP0628083A1 Heterologous gene expression in lactococcus, and the expression products therefrom
12/14/1994	EP0628079A1 Hepatitis c virus peptides
12/14/1994	EP0628077A1 Humanised antibodies directed against a33 antigen
12/14/1994	EP0628056A1 Directed human immune globulin for the prevention and treatment of staphylococcal infections
12/14/1994	EP0628054A1 Car receptors and related molecules and methods
12/14/1994	EP0628053A1 Hepatitis e virus peptide antigens and antibodies
12/14/1994	EP0627940A1 Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells
12/14/1994	EP0627936A1 Feline infectious peritonitis vaccine and method of preparation
12/14/1994	EP0627935A1 Improved vaccin against brucella abortus
12/14/1994	EP0627934A1 Early antigen for autoimmune diabetes
12/14/1994	EP0627933A1 Bystander suppression of autoimmune diseases
12/14/1994	EP0627923A1 Therapeutic domains of von willebrand factor
12/14/1994	EP0496813B1 Liposome microreservoir composition and method
12/14/1994	EP0382840B1 Aloe compositions and uses thereof
12/14/1994	EP0380607B1 Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen
12/14/1994	EP0101681B1 Antibody to a mediator activity composition and its use in a pharmaceutical composition
12/14/1994	CN1096224A Multile emulsions and methods of preparation
12/14/1994	CN1096223A Vaccines raising immunological response against viruses causing porcing respiratory and reproductive diseases
12/13/1994	US5372933 Antibody-polypeptide immunocomplex
12/13/1994	US5372928 Hepatitis C virus isolates
12/13/1994	US5372812 Composition and method for acceleration of clot lysis
12/13/1994	CA1333471C Whey protein concentrate as food supplement
12/08/1994	WO1994028413A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
12/08/1994	WO1994028161A1 Antibodies specific for dcc gene product
12/08/1994	WO1994028145A2 Expression of urokinase plasminogen activator inhibitors
12/08/1994	WO1994028138A1 Multiple sclerosis virus
12/08/1994	WO1994028137A1 Regulator of contact-mediated hemolysin
12/08/1994	WO1994028134A1 Lymphocyte chemoattractant factor and uses thereof
12/08/1994	WO1994028132A2 Opioid receptors: compositions and methods
12/08/1994	WO1994028113A1 Immortalization of denditric cells with v-myc oncogene
12/08/1994	WO1994028027A1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
12/08/1994	WO1994028026A1 Genetically engineered immunoglobulins
12/08/1994	WO1994028025A1 Methods and compositions for inhibiting cd14 mediated cell activation
12/08/1994	WO1994028023A1 Cell surface protein expressed on human cortical thymocyte and their use
12/08/1994	WO1994028016A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1)
12/08/1994	WO1994027637A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
12/08/1994	WO1994027636A1 Adjuvants for vaccines against respiratory syncytial virus
12/08/1994	WO1994027635A1 Compositions and methods for treating cancer and hyperproliferative disorders
12/08/1994	WO1994027634A1 Cryptic peptides for use in inducing immunologic tolerance
12/08/1994	WO1994027623A1 Anti-cholesterolemic egg, vaccine and method for production, and use
12/08/1994	WO1994027622A1 Surrogate tolerogenesis for the development of tolerance to xenografts
12/08/1994	WO1994027556A2 Animal model for hepatitis virus infection
12/08/1994	WO1994027435A1 Genetic immunization with cationic lipids
12/08/1994	WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
12/08/1994	WO1994024296A3 Recombinant bovine herpesvirus type 1 vaccines
12/08/1994	WO1994024291A3 Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation
12/08/1994	WO1994024163A3 Bispecific antigen-binding molecules
12/08/1994	WO1994021807A3 Defective mutant non-retroviral virus (e.g. hsv) as vaccine
12/08/1994	CA2168686A1 Process for growing a virus
12/08/1994	CA2164428A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
12/08/1994	CA2164326A1 Cryptic peptides for use in inducing immunologic tolerance
12/08/1994	CA2164102A1 Immortalization of denditric cells with v-myc oncogene
12/08/1994	CA2163737A1 Anti-cholesterolemic egg, vaccine and method for production and use
12/08/1994	CA2163652A1 Compositions and methods for treating cancer and hyperproliferative disorders
12/08/1994	CA2163550A1 Adjuvants for vaccines against respiratory syncytial virus
12/08/1994	CA2163438A1 Regulator of contact-mediated hemolysin
12/08/1994	CA2163422A1 Antibodies specific for dcc gene product
12/08/1994	CA2163350A1 Opioid receptors: compositions and methods
12/08/1994	CA2163125A1 Genetically engineered immunoglobulins
12/08/1994	CA2162855A1 Expression of urokinase plasminogen activator inhibitors
12/08/1994	CA2161979A1 Cloning, expression and uses of dorsalin-1
12/07/1994	EP0627006A1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin.
12/07/1994	EP0627005A1 Ibv spike protein (2)
12/07/1994	EP0627004A1 Improvements in or relating to malaria vaccine
12/07/1994	EP0627002A1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4
12/07/1994	EP0626847A1 Histamine derivatives and methods for their use as immunomodulators
12/07/1994	EP0626805A1 Protective effects of mutated superantigens
12/07/1994	EP0469079B1 Non-absorbable cholesterol esterase inhibitors for decreasing cholesterol absorption
12/07/1994	EP0414689B1 Pox virus vectors
12/07/1994	CN1095951A Poly I:C compound immunologic adjuvant and vaccine containing the adjuvant
12/06/1994	US5371197 Protein-dimeric polysaccharide conjugate vaccine
12/06/1994	US5371196 Process for producing secretory immunoglobulin A preparations
12/06/1994	US5370991 Cloned gene encoding human monocyte elastase inhibitor
12/06/1994	US5370872 Coupling lipid a free polysaccharide to toxin A
12/06/1994	US5370871 Vaccine; antibody inhibitors
12/06/1994	CA1333442C Wavelength-specific cytotoxic agents
11/1994
11/30/1994	EP0626452A1 Vaccine against Streptococcus suis infection
11/30/1994	EP0626447A1 Monoclonal antibodies and Fv specific for cd2 antigen

1 ... 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 ... 1823